Cargando…

Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome

Acute respiratory distress syndrome (ARDS), associated with high mortality rate, affects up to 67% of hospitalized COVID-19 patients. Early evidence indicated that the pathogenesis of COVID-19 evoked ARDS is, at least partially, mediated by hyperinflammatory cytokine storm in which interleukin 6 (IL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Segú-Vergés, Cristina, Artigas, Laura, Coma, Mireia, Peck, Richard W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931125/ https://www.ncbi.nlm.nih.gov/pubmed/36791125 http://dx.doi.org/10.1371/journal.pone.0280677

Ejemplares similares

Application of systems biology-based in silico tools to optimize treatment strategy identification in Still’s disease
por: Segú-Vergés, Cristina, et al.
Publicado: (2021)

Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach
por: Lozano, Maria L., et al.
Publicado: (2021)

In silico clinical trial evaluating lisdexamfetamine’s and methylphenidate’s mechanism of action computational models in an attention-deficit/hyperactivity disorder virtual patients’ population
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2023)

In silico evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez-Casares, José Ramón, et al.
Publicado: (2023)

Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system
por: Segú-Vergés, Cristina, et al.
Publicado: (2022)

Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab
por: Valls, Raquel, et al.
Publicado: (2023)

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Head to head evaluation of second generation ALK inhibitors brigatinib and alectinib as first-line treatment for ALK+ NSCLC using an in silico systems biology-based approach
por: Carcereny, Enric, et al.
Publicado: (2021)

Analysis of Multifocal Visual Evoked Potentials Using Artificial Intelligence Algorithms
por: Klistorner, Samuel, et al.
Publicado: (2022)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Corticosteroids in acute respiratory distress syndrome: outcomes obscured by mortality
por: Oh, Dong Kyu
Publicado: (2021)

Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
por: Romeo-Guitart, David, et al.
Publicado: (2018)

Using Artificial Intelligence for Automatic Segmentation of CT Lung Images in Acute Respiratory Distress Syndrome
por: Herrmann, Peter, et al.
Publicado: (2021)

Ultrasound Lung Image under Artificial Intelligence Algorithm in Diagnosis of Neonatal Respiratory Distress Syndrome
por: Wu, Yuhan, et al.
Publicado: (2022)

Collaborative strategies for deploying artificial intelligence to complement physician diagnoses of acute respiratory distress syndrome
por: Farzaneh, Negar, et al.
Publicado: (2023)

Evaluation of the role of lisdexamfetamine on attention-deficit/hyperactivity disorder common psychiatric comorbidities: mechanistic insights on binge eating disorder and depression
por: Gutiérrez Casares, J.R., et al.
Publicado: (2022)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

Artificial intelligence–based solutions for early identification and classification of COVID-19 and acute respiratory distress syndrome
por: Sujathakrishamoorthy, et al.
Publicado: (2021)

Do we know enough to recommend corticosteroids in acute respiratory distress syndrome?
por: Blot, Mathieu, et al.
Publicado: (2017)

Medicinal nicotine in COVID-19 acute respiratory distress syndrome, the new corticosteroid
por: Ahmad, Farrukh
Publicado: (2022)

Tocilizumab for COVID-19 Acute Respiratory Distress Syndrome: Outcomes Assessment Using the WHO Ordinal Scale
por: Nasir, Nosheen, et al.
Publicado: (2020)

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression and respiratory distress caused by cytokine storm
por: Artigas, Laura, et al.
Publicado: (2020)

The Relationship between Antenatal Corticosteroid Administration-to-Delivery Intervals and Neonatal Respiratory Distress Syndrome and Respiratory Support
por: Li, Lixia, et al.
Publicado: (2022)

Artificial intelligence–aided diagnosis model for acute respiratory distress syndrome combining clinical data and chest radiographs
por: Pai, Kai-Chih, et al.
Publicado: (2022)

A narrative review of progress in the application of artificial intelligence in acute respiratory distress syndrome: subtypes and predictive models
por: Bai, Yu, et al.
Publicado: (2022)

Acute respiratory distress syndrome: prevention and early recognition
por: de Haro, Candelaria, et al.
Publicado: (2013)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023)

Recovery of COVID-19 acute respiratory distress syndrome with tocilizumab: successful outcome in two critically ill patients
por: Cala-García, Juan David, et al.
Publicado: (2020)

Retracted: The Relationship between Antenatal Corticosteroid Administration-to-Delivery Intervals and Neonatal Respiratory Distress Syndrome and Respiratory Support
por: Healthcare Engineering, Journal of
Publicado: (2023)

A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence
por: Suri, Jasjit S., et al.
Publicado: (2021)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Correlation Between Anosmia and Severity Along with Requirement of Tocilizumab in COVID-19 Patients
por: Silu, Manju, et al.
Publicado: (2021)

Effects of artificial intelligence aibo intervention on alleviating distress and fear in children
por: Tanaka, Kyoko, et al.
Publicado: (2022)

Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome
por: Gupta, Sudeendra, et al.
Publicado: (2020)

Association of Tocilizumab and Invasive Aspergillosis in Critically Ill Patients with Severe COVID-19 Pneumonia and Acute Respiratory Distress Syndrome
por: Wu, Kuo-Lun, et al.
Publicado: (2022)

Prolonged corticosteroid treatment in acute respiratory distress syndrome: impact on mortality and ventilator-free days
por: Meduri, Gianfranco Umberto, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e6cq5hjk4i9mo9q8s6q0qlt689